(Q34283103)

1 August 2017

1 reference

title

Cardiovascular drug-drug interactions (English)

1 reference

1 August 2017

1 reference

0 references

Anderson JR

1

1 reference

1 August 2017

Nawarskas JJ

series ordinal

2

1 reference

1 August 2017

publication date

1 May 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

215-34, v

1 reference

Nifedipine--phenytoin interaction

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Gemfibrozil interaction with warfarin sodium (coumadin)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Allopurinol and enalapril. Drug induced anaphylactic coronary spasm and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

1 reference

7 January 2021

The effect of enzyme induction on the metabolism of disopyramide in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction between fenofibrate and warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The interaction of diltiazem with lovastatin and pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Grapefruit juice-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Quinidine and digoxin. An important interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Atenolol inhibits the elimination of disopyramide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Nicardipine increases cyclosporin blood levels

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Evaluation of the Pharmacokinetic and Pharmacodynamic Interaction Between Quinidine and Nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction between Clonidine and Desipramine in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Decreased bioavailability of digoxin due to hypocholesterolemic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Fluoxetine impairs the CYP2D6-mediated metabolism of propafenone enantiomers in healthy Chinese volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Letter: Clonidine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Postmarketing surveillance of captopril for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The physiological and pharmacological roles of cytochrome P450 isoenzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Cyclosporine-amiodarone interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Cimetidine inhibits renal procainamide clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Ticlopidine-theophylline interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effects of metoprolol and propranolol on theophylline elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction between disopyramide and practolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effect of fluvoxamine on the pharmacokinetics of quinidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Cimetidine and bioavailability of labetalol.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Bradycardia induced by interaction between quinidine and ophthalmic timolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Heart block in a patient on propranolol and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effect of Clinoril (sulindac, MSD), piroxicam and placebo on the hypotensive effect of propranolol in patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic evaluation of the digoxin-amiodarone interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Apparent reduced absorption of gemfibrozil when given with colestipol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction of amiodarone and diphenylhydantoin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Prazosin: the first-dose phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The potentiation of warfarin anticoagulation by amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Letter: Clonidine withdrawal and blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The mechanism of the interaction between amiodarone and warfarin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Increased procainamide plasma concentrations caused by quinidine: a new drug interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Hypertensive crisis induced by interaction of clonidine with imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Enhanced elimination of warfarin during treatment with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Itraconazole greatly increases plasma concentrations and effects of felodipine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction between warfarin and propafenone in healthy volunteer subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Itraconazole increases plasma concentrations of quinidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Eprosartan does not affect the pharmacodynamics of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The incidence, magnitude, and time course of the amiodarone-warfarin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Asystole produced by the combination of amiodarone and digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Trimethoprim alters the disposition of procainamide and N-acetylprocainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction between propranolol and propafenone in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The effects of oral propranolol, digoxin and combination therapy on the resting and exercise electrocardiogram

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Theophylline toxicity after propafenone treatment: evidence for drug interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Sinus arrest and hypotension with combined amiodarone-diltiazem therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Verapamil inhibits cyclosporin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effect of cimetidine on quinidine bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Amiodarone-cyclosporine interaction in cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction between warfarin sodium and amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Possible interaction between amiodarone and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Dose-dependence of atenolol-ampicillin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Adverse effects of combined propranolol and chlorpromazine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The interaction between H2-receptor antagonists and beta-adrenoceptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic and Pharmacodynamic Interactions between Furosemide and Hydrochlorothiazide in Nephrotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

[Acceleration of amiodarone elimination by cholestyramine]

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Influence of spironolactone on serum digoxin concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Digoxin-verapamil interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Fatal Stevens-Johnson syndrome in a patient on captopril and allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The effect of ibuprofen on serum digoxin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Potentially fatal interaction between erythromycin and disopyramide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The diltiazem-digoxin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Antagonism between non-steroidal anti-inflammatory drugs and diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Lovastatin, nicotinic acid, and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Cimetidine increases steady state plasma levels of propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Phenytoin toxicity associated with ticlopidine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The digoxin-amiodarone interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Use of labetalol in hypertensive patients during discontinuation of clonidine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effect of amiodarone on serum quinidine and procainamide levels

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Reduced induction of drug metabolism in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Fever, myalgia, and arthralgia in a patient on captopril and allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Atenolol interaction with aspirin, allopurinol, and ampicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Renal function and digoxin clearance during quinidine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Drug-interaction-induced rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Digitalis toxicity and hypomagnesemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Amiodarone--phenytoin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Flecainide and amiodarone interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Elevation of thioridazine plasma levels by propranolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The effect of quinidine on the analgesic effect of codeine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Influence of cimetidine on verapamil kinetics and dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Cimetidine-procainamide pharmacokinetic interaction in man: Evidence of competition for tubular secretion of basic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Clonidine withdrawal complicated by amitriptyline therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Potential interaction between warfarin and fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Increased quinidine plasma concentrations during administration of verapamil: a new quinidine-verapamil interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Quinidine-nifedipine interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Inhibition of propranolol metabolism by chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Drug interaction between propafenone and metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Interaction of metoprolol and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Amiodarone reduces plasma warfarin clearance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

The effect of ranitidine and cimetidine on single-dose diltiazem pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970209-5

7 January 2021

10.1016/S0733-8651(05)70209-5

Identifiers

DOI

1 reference

1 August 2017

1 reference